<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>conference; presentation Archives - Relaxera</title>
	<atom:link href="https://relaxera.de/tag/conference-presentation/feed/" rel="self" type="application/rss+xml" />
	<link>https://relaxera.de/tag/conference-presentation/</link>
	<description></description>
	<lastBuildDate>Wed, 27 Nov 2024 10:49:12 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.5</generator>

<image>
	<url>https://relaxera.de/wp-content/uploads/2017/07/cropped-Logo_Relaxera_144x144-32x32.png</url>
	<title>conference; presentation Archives - Relaxera</title>
	<link>https://relaxera.de/tag/conference-presentation/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Cardiology World Conference CARDIO 2024</title>
		<link>https://relaxera.de/events/d-a-c-h-region-congress-heart-failure-2/</link>
		
		<dc:creator><![CDATA[Marion Michaelis]]></dc:creator>
		<pubDate>Fri, 15 Nov 2024 12:46:27 +0000</pubDate>
				<category><![CDATA[Events]]></category>
		<category><![CDATA[conference; presentation]]></category>
		<guid isPermaLink="false">https://relaxera.de/?p=2279</guid>

					<description><![CDATA[<p>The Cardiology World Conference CARDIO 2024 takes place September  5 - 7, 2024, in Madrid, Spain.<br />
The lecture of Thomas Bernd Dschietzig is about treatment of HFpEF and focuses on pre-clinical experiments and results with relaxin-2, explaining the bolus therapy and the signalling portfolio of the native peptide.<br />
Relaxin-2 delivery reverses diastolic dysfunction, arrhythmia susceptibility, inflammation, and excess fibrosis.<br />
...</p>
<p>The post <a href="https://relaxera.de/events/d-a-c-h-region-congress-heart-failure-2/">Cardiology World Conference CARDIO 2024</a> appeared first on <a href="https://relaxera.de">Relaxera</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>The Cardiology World Conference CARDIO 2024 takes place September  5 &#8211; 7, 2024, in Madrid, Spain.</p>
<p>The lecture of Thomas Bernd Dschietzig is about treatment of HFpEF and focuses on pre-clinical experiments and results with relaxin-2, explaining the bolus therapy and the signalling portfolio of the native peptide.<br />
Relaxin-2 delivery reverses diastolic dysfunction, arrhythmia susceptibility, inflammation, and excess fibrosis.<br />
Get a summary of the presentation <a href="https://relaxera.de/wp-content/uploads/2024/11/Madrid2024_summary-presentation.pdf">here</a> an view the whole presentation using this <a href="https://youtu.be/Rus_hd76vsA">youtube</a> link.</p>
<p>Relaxera is currently preparing a phase II clinical trial in HFpEF.</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>The post <a href="https://relaxera.de/events/d-a-c-h-region-congress-heart-failure-2/">Cardiology World Conference CARDIO 2024</a> appeared first on <a href="https://relaxera.de">Relaxera</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>D-A-C-H-Region Congress  “Heart Failure”</title>
		<link>https://relaxera.de/events/d-a-c-h-region-congress-heart-failure/</link>
		
		<dc:creator><![CDATA[Marion Michaelis]]></dc:creator>
		<pubDate>Fri, 16 Jun 2023 12:01:13 +0000</pubDate>
				<category><![CDATA[Events]]></category>
		<category><![CDATA[conference; presentation]]></category>
		<guid isPermaLink="false">https://relaxera.de/?p=2232</guid>

					<description><![CDATA[<p>The Heart Failure Congress takes place September  28 – 30, 2023, in Göttingen, Germany. The lectures focus on heart failure treatment options, HFpEF, on electrophysiology, diagnostics, operative and intervention heart failure treatment and additional with a view on several comorbidities. On September 28, the session “Pipeline for the therapy of heart failure” (at 1 pm)  [...]</p>
<p>The post <a href="https://relaxera.de/events/d-a-c-h-region-congress-heart-failure/">D-A-C-H-Region Congress  “Heart Failure”</a> appeared first on <a href="https://relaxera.de">Relaxera</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>The <a href="https://herzzentrum.umg.eu/ueber-uns/veranstaltungen/news-details/news-detail/detail/news/dreilaendertreffen-herzinsuffizienz/">Heart Failure Congress </a>takes place September  28 – 30, 2023, in Göttingen, Germany.</p>
<p>The lectures focus on heart failure treatment options, HFpEF, on electrophysiology, diagnostics, operative and intervention heart failure treatment and additional with a view on several comorbidities.</p>
<p>On September 28, the session “Pipeline for the therapy of heart failure” (at 1 pm) includes a presentation by Thomas Dschietzig about relaxin-2 as treatment option.</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>The post <a href="https://relaxera.de/events/d-a-c-h-region-congress-heart-failure/">D-A-C-H-Region Congress  “Heart Failure”</a> appeared first on <a href="https://relaxera.de">Relaxera</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Presentation at European Society of Cardiology (ESC) Congress 2022 in Barcelona</title>
		<link>https://relaxera.de/events/presentation-at-european-society-of-cardiology-esc-congress-2022-in-barcelona-2/</link>
		
		<dc:creator><![CDATA[Marion Michaelis]]></dc:creator>
		<pubDate>Mon, 18 Jul 2022 13:56:17 +0000</pubDate>
				<category><![CDATA[Events]]></category>
		<category><![CDATA[conference; presentation]]></category>
		<guid isPermaLink="false">https://relaxera.de/?p=1836</guid>

					<description><![CDATA[<p>First results of our cooperation with University of Pittsburgh Medical Center, UPMC, were presented during the ESC congress 2022 in Barcelona by Prof. Dr. Guy Salama in the session "HFpEF and HFmrEF: what’s new in treatment" - “The therapeutic potential of relaxin for heart failure with preserved ejection fraction” You will learn about relaxin-2-[...]</p>
<p>The post <a href="https://relaxera.de/events/presentation-at-european-society-of-cardiology-esc-congress-2022-in-barcelona-2/">Presentation at European Society of Cardiology (ESC) Congress 2022 in Barcelona</a> appeared first on <a href="https://relaxera.de">Relaxera</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>First results of our cooperation with University of Pittsburgh Medical Center, UPMC, were presented during the <a href="https://esc365.escardio.org/esc-congress/sessions/4573-hfpef-and-hfmref-whats-new-in-treatment">ESC congress 2022</a> in Barcelona by Prof. Dr. Guy Salama in the session</p>
<p>&nbsp;</p>
<p><strong>&#8220;HFpEF and HFmrEF: what’s new in treatment&#8221; &#8211; </strong><strong>“The therapeutic potential of relaxin for heart failure with preserved ejection fraction”</strong></p>
<p>You will learn about relaxin-2 &#8211; Wnt1-interaction and gain insight into relaxin’s pleitropic actions and its ability to reverse maladaptive remodeling of atrial tissue and suppress fibrosis.<br />
Read the abstract <a href="https://relaxera.de/wp-content/uploads/2022/10/ESC-Congress-2022-in-Barcelona.pdf">here</a>.</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>The post <a href="https://relaxera.de/events/presentation-at-european-society-of-cardiology-esc-congress-2022-in-barcelona-2/">Presentation at European Society of Cardiology (ESC) Congress 2022 in Barcelona</a> appeared first on <a href="https://relaxera.de">Relaxera</a>.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
